Outstanding Results for the Treatment of Lung Cancer

Professor Tony Mok, Chairman of the Department of Clinical Oncology at the Chinese University of Hong Kong, presents two outstanding lung cancer results from ASCO 2024 in this MEDtalk. He also gives his perspective on a new KRAS-G12C inhibitor based on the CRYSTAL-12 trial.